SUSQUEHANNA INTERNATIONAL GROUP, LLP - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$983,310
+373.3%
52,781
+560.0%
0.00%
Q2 2023$207,762
-75.6%
7,997
-73.1%
0.00%
Q1 2023$852,726
-42.5%
29,691
-40.7%
0.00%
Q4 2022$1,482,960
-8.5%
50,100
-26.4%
0.00%
Q3 2022$1,621,000
+106.8%
68,065
+118.1%
0.00%
Q1 2022$784,000
-22.2%
31,206
+10.9%
0.00%
Q4 2021$1,008,000
+16.5%
28,128
+38.3%
0.00%
Q3 2021$865,000
+167.0%
20,338
+171.4%
0.00%
Q2 2021$324,000
-74.6%
7,495
-76.0%
0.00%
Q1 2021$1,276,000
-69.9%
31,288
-66.6%
0.00%
Q4 2020$4,246,000
+1214.6%
93,798
+927.6%
0.00%
Q3 2020$323,000
-86.6%
9,128
-85.7%
0.00%
Q2 2020$2,414,000
-5.4%
64,000
-27.5%
0.00%
Q1 2020$2,551,000
-70.2%
88,223
-46.6%
0.00%
-100.0%
Q4 2019$8,561,000
+22.8%
165,120
+30.0%
0.00%
+50.0%
Q3 2019$6,971,000
+44.4%
126,984
+6.8%
0.00%
Q2 2019$4,827,000
+93.3%
118,854
+43.9%
0.00%
-100.0%
Q1 2019$2,497,000
+112.0%
82,600
+135.6%
0.00%
Q4 2018$1,178,000
-79.0%
35,054
-73.7%
0.00%
-100.0%
Q3 2018$5,622,000
-12.5%
133,300
-33.6%
0.00%
-50.0%
Q2 2018$6,427,000
+102.0%
200,865
+213.9%
0.00%0.0%
Q1 2018$3,182,000
+469.2%
64,000
+517.1%
0.00%
Q4 2017$559,000
-74.9%
10,371
-73.0%
0.00%
-100.0%
Q3 2017$2,227,000
-22.3%
38,400
-33.9%
0.00%0.0%
Q2 2017$2,867,000
+32.0%
58,100
+16.2%
0.00%0.0%
Q1 2017$2,172,000
-18.2%
50,000
-7.8%
0.00%0.0%
Q4 2016$2,654,000
+4.2%
54,207
+1.9%
0.00%0.0%
Q3 2016$2,546,000
-41.4%
53,200
-34.3%
0.00%
-50.0%
Q2 2016$4,346,000
-20.0%
81,000
-33.3%
0.00%
-33.3%
Q1 2016$5,434,000
+10.2%
121,500
-6.0%
0.00%
+50.0%
Q4 2015$4,930,000
-19.3%
129,200
-32.7%
0.00%
-33.3%
Q3 2015$6,109,000
-9.1%
191,903
-5.7%
0.00%0.0%
Q2 2015$6,720,000
+65.4%
203,473
+106.1%
0.00%
+50.0%
Q1 2015$4,064,000
-38.2%
98,714
-38.8%
0.00%
-33.3%
Q4 2014$6,572,000
-9.5%
161,295
-18.5%
0.00%0.0%
Q3 2014$7,259,000
+3.1%
198,000
+30.3%
0.00%
+50.0%
Q2 2014$7,041,000
+25.6%
151,973
+11.4%
0.00%
-33.3%
Q1 2014$5,605,000
+217.9%
136,380
+195.1%
0.00%
Q4 2013$1,763,000
+701.4%
46,220
+402.4%
0.00%
Q3 2013$220,0009,2000.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Trigran Investments, Inc. 954,799$23,975,0002.44%
CAPITAL MANAGEMENT CORP /VA 202,258$5,079,0001.09%
Riverwater Partners LLC 12,370$311,0000.51%
DIKER MANAGEMENT LLC 21,835$548,0000.44%
Ranger Investment Management 136,381$3,425,0000.22%
CHATHAM CAPITAL GROUP, INC. 23,757$597,0000.12%
Teton Advisors, Inc. 22,000$552,0000.10%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,412,259$35,462,0000.09%
Intercontinental Wealth Advisors, LLC 14,257$358,0000.08%
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 385,528$9,681,0000.06%
View complete list of ANIKA THERAPEUTICS INC shareholders